Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

NCT00618657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-negative Breast Cancer
HER2-positive Breast Cancer
Recurrent Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
DRUG: bevacizumab
DRUG: trastuzumab
PROCEDURE: magnetic resonance imaging
PROCEDURE: therapeutic conventional surgery

Sponsor

University of California, Irvine

Collaborators

[object Object]
[object Object]